(AGENPARL) - Roma, 17 Novembre 2022 - (AGENPARL) – gio 17 novembre 2022 WHO Media
No images? [Click here](https://worldhealthorganization.cmail19.com/t/d-e-zydykhd-iitylyihjr-q/)
Wednesday, 16 November 2022
POST PRESSER LINKS
Virtual Press Conference on Global Health Issues
Background documents on the Ebola vaccine and therapeutics trial in Uganda
Please find below links from the virtual press conference on global health issues held today, 16 November 2022 at WHO.
WHO Director-General’s opening remarks:
[WHO Director-General’s opening remarks at the global health issues media briefing – 16 November 2022](https://worldhealthorganization.cmail19.com/t/d-l-zydykhd-iitylyihjr-r/)
Audio files from today’s presser:
Listen and download:
[https://who.canto.global/b/UF00B](https://worldhealthorganization.cmail19.com/t/d-l-zydykhd-iitylyihjr-y/)
Weblink:
[https://terrance.who.int/mediacentre/presser/WHO-AUDIO_Emergencies_Press_Conference_16NOV2022.mp3](https://worldhealthorganization.cmail19.com/t/d-l-zydykhd-iitylyihjr-j/)
Length: 36mins
Background documents on the Ebola vaccine and therapeutics trial in Uganda:
Since the Ebola outbreak began in Uganda, the Government of Uganda, together with researchers, funders, companies, regulatory authorities and other experts has been working under a global effort coordinated by WHO to accelerate the development and deployment of vaccines for use in trials.
Today, WHO Director-General Dr Tedros announced that a WHO committee of external experts has evaluated three candidate vaccines and agreed that all three should be included in the planned trial in Uganda. WHO and Uganda’s Minster of Health have considered and accepted the committee’s recommendation. (Link to his remarks is above.)
We expect supplies of one of the three candidate vaccines to arrive in Uganda next week, and the other two soon after. The trial can begin once one vaccine has arrived in country, and the others will be added as they arrive.
The documents below contain more detailed information.
1. The deliberations and decisions made by the WHO Vaccine Prioritization Working Group on the three Sudan ebolavirus vaccines that are candidates for inclusion in the planned ring vaccination trial in Uganda (“Tokomeza Ebola):